Teladoc Health Q1 revenue falls, BetterHelp paying users decline

Teladoc Health

29/04/2026 21:53

Overview

U.S. virtual care provider's Q1 revenue fell 2% yr/yr, slightly beating analyst expectations

Adjusted EBITDA for Q1 beat analyst estimates

Company reaffirmed midpoint of full-year financial outlook

Outlook

Teladoc Health expects Q2 2026 revenue of $597 mln to $626 mln

Company sees full-year 2026 revenue between $2.48 bln and $2.58 bln

Teladoc Health reaffirms midpoint of its full-year 2026 financial outlook

Result Drivers

SEGMENT PERFORMANCE - Integrated Care segment revenue rose 2% while BetterHelp segment revenue fell 9%, with the company citing progress in scaling insurance acceptance for BetterHelp

REVENUE MIX SHIFT - Access fees revenue declined 8% while other revenue increased 25%, with no detailed explanation provided for these changes

RESTRUCTURING COSTS - Q1 results included $12 mln in restructuring costs, primarily related to severance

Company press release: ID:nGNX6KqJS8

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Beat*
$613.85 mln
$610.87 mln (24 Analysts)
Q1 EPS
-$0.36
Q1 Net Income
-$63.84 mln
Q1 Adjusted EBITDA
Beat
$58.17 mln
$56.71 mln (23 Analysts)
Q1 Basic EPS
-$0.36


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy", 20 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Teladoc Health Inc is $6.00, about 0% even its April 28 closing price of $6.00

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)